IBOV 171,324.31 ▼ 0.43% IPC MEX 71,811.20 ▼ 0.27% MERVAL 2,848,945 — — USD/BRL5.64▲ 0.01% USD/MXN18.61▲ 0.03% USD/CLP994.00▲ 1.14% USD/COP3,305▲ 0.78% USD/PEN3.41▲ 0.21% USD/ARS1,545▼ 0.02% USD/UYU40.52▲ 2.14% USD/PYG6,185▲ 3.33% USD/BOB11.60▼ 0.28% USD/DOP60.57▲ 1.81% USD/CRC445.25▲ 0.47% USD/GTQ7.65▲ 2.13% USD/HNL26.90▲ 2.13% USD/NIO36.62▲ 1.57% USD/VES909.35▼ 0.13% USD/PAB1.00— 0.00% USD/BZD2.00— 0.00% USD/JMD157.09▲ 1.00% USD/TTD6.71▲ 1.04% EUR/BRL6.24▲ 0.81% BRENT 95.75 ▼ 0.07% WTI 88.37 ▼ 0.42% IRON ORE 161.91 — — COPPER 6.14 ▼ 0.72% GOLD 3,906 ▲ 0.53% SILVER 50.06 ▲ 0.17% SOY 1,232 ▲ 0.43% CORN 447.25 ▲ 1.07% WHEAT 593.75 ▲ 1.63% COFFEE 275.10 ▲ 2.27% SUGAR 18.22 ▼ 1.41% ORANGE JUICE 140.60 ▼ 0.25% COTTON 78.56 ▲ 0.05% COCOA 5,187 ▲ 5.71% BEEF 223.05 ▲ 1.86% CATTLE 331.80 ▼ 0.25% LITHIUM 59.43 ▼ 2.69% PETR4 44.70 ▲ 2.64% VALE3 63.95 ▼ 0.75% ITUB4 41.68 ▼ 0.10% BBDC4 14.32 ▼ 0.07% ABEV3 15.75 ▼ 0.63% BBAS3 15.48 ▼ 8.35% B3SA3 14.76 ▼ 0.27% WEGE3 51.65 ▲ 0.08% PRIO3 63.30 ▲ 2.98% SUZB3 56.04 ▲ 4.16% RENT3 29.58 ▼ 2.18% AZZA3 16.90 ▲ 9.95% CSAN3 2.85 ▼ 5.94% RAIZ4 0.30 ▼ 98.49% PCAR3 2.39 ▼ 5.91% GMAT3 3.84 ▼ 5.88% PSSA3 45.94 ▼ 0.09% CVCB3 0.84 ▼ 2.33% POSI3 3.37 ▲ 1.51% SLCE3 18.36 ▲ 7.68% NATU3 5.33 ▼ 5.16% BRKM5 3.07 ▲ 5.14% RANI3 8.18 ▼ 2.50% CSNA3 4.23 ▼ 6.42% IBOV 171,324.31 ▼ 0.43% IPC MEX 71,811.20 ▼ 0.27% MERVAL 2,848,945 — — USD/BRL 5.64 ▲ 0.01% USD/MXN 18.62 ▲ 0.07% USD/CLP 994.00 ▲ 1.14% USD/COP 3,305 ▲ 0.78% USD/PEN 3.41 ▲ 0.21% USD/ARS 1,545 ▼ 0.02% USD/UYU 40.52 ▲ 2.14% USD/PYG 6,185 ▲ 2.16% USD/BOB 11.60 ▲ 0.86% USD/DOP 60.57 ▲ 1.81% USD/CRC 445.25 ▲ 0.47% USD/GTQ 7.65 ▲ 3.31% USD/HNL 26.90 ▲ 2.13% USD/NIO 36.62 ▲ 1.57% USD/VES 909.35 ▼ 0.13% USD/PAB 1.00 — 0.00% USD/BZD 2.00 — 0.00% USD/JMD 157.09 ▲ 1.00% USD/TTD 6.71 ▲ 1.04% EUR/BRL 6.24 ▲ 0.81% BRENT 95.75 ▼ 0.07% WTI 88.37 ▼ 0.42% IRON ORE 161.91 — — COPPER 6.14 ▼ 0.72% GOLD 3,906 ▲ 0.53% SILVER 50.06 ▲ 0.17% SOY 1,232 ▲ 0.43% CORN 447.25 ▲ 1.07% WHEAT 593.75 ▲ 1.63% COFFEE 275.10 ▲ 2.27% SUGAR 18.22 ▼ 1.41% ORANGE JUICE 140.60 ▼ 0.25% COTTON 78.56 ▲ 0.05% COCOA 5,187 ▲ 5.71% BEEF 223.05 ▲ 1.86% CATTLE 331.80 ▼ 0.25% LITHIUM 59.43 ▼ 2.69% PETR4 44.70 ▲ 2.64% VALE3 63.95 ▼ 0.75% ITUB4 41.68 ▼ 0.10% BBDC4 14.32 ▼ 0.07% ABEV3 15.75 ▼ 0.63% BBAS3 15.48 ▼ 8.35% B3SA3 14.76 ▼ 0.27% WEGE3 51.65 ▲ 0.08% PRIO3 63.30 ▲ 2.98% SUZB3 56.04 ▲ 4.16% RENT3 29.58 ▼ 2.18% AZZA3 16.90 ▲ 9.95% CSAN3 2.85 ▼ 5.94% RAIZ4 0.30 ▼ 98.49% PCAR3 2.39 ▼ 5.91% GMAT3 3.84 ▼ 5.88% PSSA3 45.94 ▼ 0.09% CVCB3 0.84 ▼ 2.33% POSI3 3.37 ▲ 1.51% SLCE3 18.36 ▲ 7.68% NATU3 5.33 ▼ 5.16% BRKM5 3.07 ▲ 5.14% RANI3 8.18 ▼ 2.50% CSNA3 4.23 ▼ 6.42%
since 2009
Friday, November 13, 2026

Covid-19 Brazil

Russia approves single-dose Sputnik V version

By · · 2 min read

RIO DE JANEIRO, BRAZIL -Russia has approved a single-dose version of the Sputnik V vaccine against Covid-19 after it demonstrated nearly 80% efficacy, according to the state fund that supported its development.

The vaccine demonstrated nearly 80% efficacy, according to the state fund that supported its development.

Russia approves single-dose Sputnik V version
Sputnik Light, a single dose version of Sputnik V Russian Covid-19 vaccine
RT
Ask Rio Times
17 years of Latin America reporting, on demand.
Open the full Ask Rio Times →

The 79.4% efficacy rate of the vaccine, called Sputnik Light, is based on an analysis of real-world data, not a standard clinical trial, and interim results from the late-stage study are expected later this month, according to a statement from the Russian Direct Investment Fund (RDIF). Initial and intermediate studies have shown no serious adverse events, the RDIF said.

One dose of Sputnik Light “significantly reduces the possibility of severe cases leading to hospitalization,” the RDIF said in the statement.

Russia’s two-dose Sputnik V vaccine rivaled other major vaccines used in the United States and Europe when it demonstrated 92% efficacy against Covid-19 in a peer-reviewed study.

The LatAm Brief

One email, every weekday morning. What moved in Latin American markets, politics and expat life.

Yesterday’s subject line: “Colombia's president announces a new cartel airstrike”

The vaccine sparked skepticism when President Vladimir Putin announced last August that Russia had cleared the world’s first Covid-19 vaccine for use before safety trials had even been completed.

Although the RDIF claims that more than 20 million people worldwide have already been administered a dose of Sputnik V, Russia is facing challenges in persuading its own citizens to be vaccinated. Only about 8% of the population has been administered the first dose amid fears of a growing wave of cases.

The two-dose Sputnik V will continue to be the main vaccine in Russia, Kirill Dmitriev, RDIF director-president, said in a telephone interview. The light version, he said, is primarily for countries with a significant increase in Covid cases that need to be quickly reduced.

“We expect registration of Sputnik Light in several countries as early as next week,” Dmitriev said, adding that the fund followed Russian regulatory procedures.

This article was produced by The Rio Times’ automated AI newsroom. Editorial responsibility: Matthias Camenzind, Publisher and Editor-in-Chief. The Rio Times also runs Ask Rio Times, which answers from 100,000+ of our own articles, the daily Latin America Power Map, and prediction-market odds on elections and markets.. How we use AI · Report an error

The Rio Times · Power Map
See who really holds power in Latin America
Click to open the Power Map →

Brazil runoff date: Sunday, October 25, poll closing times and when results start · Brazil runoff polls: Flávio 51%, Lula 49% · Kalshi and Polymarket odds

Rotate for Best Experience

This report is optimized for landscape viewing. Rotate your phone for the full experience.